title: Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia.
authors: Department of Neurology, Hannover Medical School (MHH), Hannover, Germany.
authors: Kaweh
authors: K
authors: Pars
authors: Niklas
authors: N
authors: Garde
authors: Thomas
authors: T
authors: Skripuletz
authors: Refik
authors: R
authors: Pul
authors: Reinhard
authors: R
authors: Dengler
authors: Martin
authors: M
authors: Stangel
mesh_terms: D000368:Aged; D003680:Deglutition Disorders / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007271:Injections, Intradermal / Q000706:statistics & numerical data; D008297:Male; D018979:Myositis, Inclusion Body / Q000150:complications / Q000276:immunology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous